References
- Powell JJ, Wojnarowska F. Lichen sclerose. Lancet 1999; 353(9166):1777–83
- Vontver LA. Management of vulvar diseases. In: Stenchever MA, ed. Office gynecology. St Louis: CV Mosby, 1992:247–95
- Bornstein J, Heifetz S, Kellner Y, et al. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gynecol 1998; 178(1 Pt 1):80–4
- Lorenz B, Kaufman RH, Kutzner SK. Liehen sclerosus: therapy with clobetasol propionate. J Reprod Med 1998; 43(9):790–4
- Ridley CM. Lichen sclerosus. Dermatol Clin 1992; 10(2):309–23
- Sinha P, Sorinola O, Luesley DM. Lichen sclerosus of the vulva: long-term steroid maintenance therapy. J Reprod Med 1999; 44(7):621–4
- Joura EA, Zeisler H, Bancher-Todesca D, et al. Short-term effects of topical testosterone in vulvar lichen sclerosus. Obstet Gynecol 1997; 89(2):297–9
- Abramov Y, Elchalal U, Abramov D, et al. Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv 1996; 51 (3): 193–9
- Pincus SH. Vulvar dermatoses and pruritus vulvae. Dermatol Clin 1992; 10(2): 297–308
- Turner ML, Marinoff SC. General principles in the diagnosis and treatment of vulvar diseases. Dermatol Clin 1992; 10(2): 275–81
- Clark TJ, Etherington IJ, Luesley DM. Response of vulvar lichen sclerosus and squamous cell hyperplasia to graduated topical steroids. J Reprod Med 1999; 44(11):958–62
- Smith RP. Vulvitis and vaginal infections. In: Smith RP. Gynecology in primary care. Baltimore: Williams & Wilkins, 1997: 603–32
- Apgar BS, Cox JT. Differentiating normal and abnormal findings of the vulva. Am Fam Physician 1996; 53(4):1171–80
- Sillman FH, Muto MG. The vulva. In: Ryan KJ, Berkowitz RS, Barbieri RL, eds. Kistner's gynecology: principles and practice. 6th ed. St Louis: CV Mosby, 1995:61
- Fitzpatrick TB, Johnson RA, Wolff K, et al, eds. Disorders of cell kinetics and differentiation. In: Color atlas and synopsis of clinical dermatology: common and serious diseases. 3rd ed. New York: McGraw- Hill, 1997; 91:76–91
- Edwards L. Desquamative vulvitis. Dermatol Clin 1992; 10(2):325–37
- Lewis FM. Vulvar lichen planus. Br J Dermatol 1998; 138(4):569–75
- Hopkins MP, Snyder MK. Benign disorders of vulva and vagina. In: Curtis MG, Hopkins MP, eds. Glass's office gynecology. 5th ed. Baltimore: Williams & Wilkins, 1999:417–26
- Camisa C, Sexton C, Friedman C. Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression: a case report. J Reprod Med 1989; 34(8):543–6
- Brown CF, Gallup DG, Brown VM. Hidradenitis suppurativa of the anogenital region: response to isotretinoin. Am J Obstet Gynecol 1988; 158(1): 12–5
- Thomas R, Barnhill D, Bibro M, et al. Hidradenitis suppurativa: a case presentation and review of the literature. Obstet Gynecol 1985; 66(4):592–5
- Turner ML. Vulvar manifestations of systemic diseases. Dermatol Clin 1992; 10(2):445–58
- Hill DA, Lense JJ. Office management of Bartholin gland cysts and abscesses. Am Fam Physician 1998; 57(7):1611–6
- Rock B. Pigmented lesions of the vulva. Dermatol Clin 1992; 10(2):361–70
- Sawchuk WS. Vulvar manifestations of human papillomavirus infection. Dermatol Clin 1992; 10(2):405–14
- Lynch PJ, Edwards L. Genital dermatology. New York: Churchill Livingstone, 1994:144
- Kaufmann T, Pawl NO, Soifer I, et al. Cystic papillary hidradenoma of the vulva: case report and review of the literature. Gynecol Oncol 1987; 26(2):240–5